* Microbot Medical Inc MBOT.OQ reported a quarterly
adjusted
loss of 36 cents per share for the quarter ended in March. The
lone analyst forecast for the quarter was for a loss of 45 cents
per share.
* Reported revenue was zero.
* Microbot Medical Inc's reported EPS for the quarter was a
loss
of 36 cents.
* The mean earnings estimate of analysts had risen by
about 2.2%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
* Microbot Medical Inc shares had fallen by 41.8% this
quarter and
lost 59.8% so far this year.
* The company reported a quarterly loss of $2.85 million.
* Wall Street's median 12-month price target for Microbot
Medical
Inc is $8.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
17 at 10:56 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.45 -0.36 Beat
Dec. 31 2022 -0.47 -0.41 Beat
Sep. 30 2022 -0.51 -0.49 Beat
Jun. 30 2022 -0.45 -0.49 Missed